Mitochondrial membrane from bovine heart muscle (Keilin-Hartree submitochondrial particles [KHP]) was adjusted to 576 mL with 100 mM sodium phosphate buffer, pH 7.4. Fifty milliliters of 40% (w/v) sodium cholate (Dojindo, highest grade) was added to the mitochondrial membrane fraction, and then ammonium sulfate was added to 33% saturation at 0 °C while stirring (30 min). During this process, the pH of this mixture was kept between 7.3 and 7.4 by addition of 3 M NaOH. The supernatant obtained by centrifugation for 20 min at 25,000 g was measured, and ammonium sulfate was added to 50% saturation. After centrifugation for 25 min at 25,000 g, the precipitants were dissolved in 100 mM sodium phosphate buffer (pH 7.4) containing 0.5% (w/v) sodium cholate, and the volume was adjusted to 220 mL. The solution was dialyzed (dialysis membrane pore size: 14,000) against 3,000 mL of 40 mM sodium phosphate buffer (pH 7.4) for 90 min, followed by centrifugation at 100,000 g for 40 min. The precipitants were re-solubilized in 100 mM sodium phosphate buffer (pH 7.4) containing 2.0% (w/v) sodium cholate, the volume was adjusted 200 mL, and ammonium sulfate was added to 25% saturation at 0 °C. After incubation at 0 °C for 20 min, the solution was centrifuged at 35,000 g for 10 min. The ammonium sulfate saturation of the supernatant was increased to 45%, and then the supernatant was centrifuged at 35,000 g for 10 min. The precipitants were dissolved in 200 mL of 100 mM sodium phosphate buffer (pH 7.4), containing 0.5% (w/v) sodium cholate. Ammonium sulfate fractionation between 25% and 40% saturation was performed using the procedure described above. The resultant precipitants were dissolved in 130 mL of 100 mM sodium phosphate buffer (pH 7.4) containing 0.5% (w/v) sodium cholate. Ammonium sulfate fractionation between 25% and 35% saturation was performed using the procedure described above. The resultant precipitants were dissolved in 200 mL of 100 mM sodium phosphate buffer (pH 7.4) containing 0.2% (w/v) 3-oxatridecyl--D-mannoside (3OM), and the detergent was switched from sodium cholate to 3OM. Ammonium sulfate fractionation between 35% and 55% saturation was performed using the procedure described above, except that the 20min incubation was eliminated. The resultant precipitants were dissolved in 100 mL of 100 mM sodium phosphate buffer (pH 7.4) containing 0.2% (w/v) DM, and stored overnight at 0 °C. After the volume was adjusted to 220 mL with the same buffer containing 0.2% (w/v) 3OM, ammonium sulfate fractionation between 40% and 60% saturation was performed. The resultant precipitants were dissolved in 200 mL of 100 mM sodium phosphate buffer (pH 7.4) containing 0.2% (w/v) 3OM, and ammonium sulfate fractionation between 45% and 70% saturation was performed. The resultant floating precipitants were collected and dissolved in 15-20 mL of 100 mM sodium phosphate buffer (pH 7.4), containing 0.2 % (w/v) 3OM, and then dialyzed against 3 L of 50 mM sodium phosphate buffer (pH 6.2) (replaced three times: the first liter for 1 h, the second for 2 h, and the third for 3 h, for a total of 6 h). After dialysis, the sample was centrifuged at 35,000 g for 20 min, and the supernatant was concentrated to 80-90 mg protein/mL with the Amicon Diaflo apparatus using an ultrafiltration membrane (Advantec) with a pore size of 200,000. To determine the concentration of CcO, the absorption spectra of sample were measured after reduction of enzymes by dithionite, using the extinction coefficient ε red 604 -630 nm = 46.6 mM −1 cm −1 (1).
120 μL), covering it with a coverslip so that air could not enter, and leaving the solution to stand at 4 °C. CcO crystals were obtained within 1-2 weeks.
Preparation and activity measurement of amphipol-solubilized monomeric and dimeric CcOs
Amphipol-solubilized monomeric CcO were prepared by the method as described below (2) . Crystalline CcO (5 mg) solubilized with 0.2 % (w/v) DM in 100 mM sodium phosphate buffer (pH 7.4) (1) was treated with 2 % (w/v) octyl glucopyranoside at 0°C for 120 min before the addition of amphipol (amphipol-to-protein weight ratio, 3:1). One milliliter of 1 % (w/v) βcyclodextrin was added to the mixture, which was then dialyzed against 100 ml of 40 mM HEPES-Na (pH 7.8) containing 1 % (w/v) β-cyclodextrin for 60 min at 4°C. The resultant mixture was centrifuged on a stepwise sucrose gradient (1.350, 1.338, 1.325, 1.315, 1.3, and 1.2 M sucrose in 40 mM HEPES-Na [pH 7.8]) at 105,000 g for 24 h at 4°C. Gradients were fractionated from bottom to top, and protein content was investigated by BN-PAGE. Amphipolsolubilized dimeric CcO was prepared as described for monomeric CcO, except that treatment with octyl glucopyranoside was omitted. Enzyme activity was measured at 20 °C in a quartz cuvette with a 1-cm light path equipped with a magnetic stirrer. A circulating water system was used to control the temperature of the cuvette holder. The enzymatic reaction was initiated by addition of 40 μL of 0.24 μM amphipol-solubilized dimeric or monomeric enzyme solution to 2 mL of 100 mM sodium phosphate buffer supplemented with reduced cytochrome c (horse heart), and the decrease in absorbance at 550 nm was monitored.
Preparation of crystals and X-ray diffraction experiment under cryogenic condition
For the X-ray diffraction experiment to collect high resolution data, the crystals were soaked in solution containing 50 mM sodium phosphate (pH 6.0), 0.05% (w/v) 3OM, 4% PEG 4000, and 35% propylene glycol as a cryoprotectant. To collect anomalous scattering data from phosphorus atoms in the phospholipids, the crystals were soaked in a solution lacking phosphorus: 50 mM MES-Tris (pH 6.2), 0.05% (w/v) 3OM, 4% PEG 4000, and 35% propylene glycol. To reduce damage to the crystal during soaking, the concentration of propylene glycol was gradually increased in seven steps. To prepare CcO in the reduced state, the crystals were soaked for 1 h in solution containing 50 mM sodium phosphate (pH 6.0), 0.05% (w/v) 3OM, 4% PEG 4000, and 35% propylene glycol supplemented with 5 mM sodium dithionite, 5 mM glucose, 1 μM glucose oxidase, and 0.5 μM catalase. Full reduction of the crystal was confirmed by measuring the α-band absorption using a micro-spectrometer equipped with a multi-channel spectrometer (USB2000, Ocean Optics) at 4 °C, as shown in Figures S5D and S5E . The crystals were frozen in a cryonitrogen stream at 100 K and stored in liquid nitrogen. Data collection was carried out at BL44XU of SPring-8. To reduce the effect of X-ray radiation damage, the crystal was translated after each series of ten X-ray exposures. The experimental conditions are summarized in Table S1 .
Processing of X-ray diffraction data and structural analysis
Data processing and scaling were performed using the DENZO and Scalepack software (3). Statistics of the data sets are summarized in Table S1 . The structure factor amplitudes were calculated using the CCP4 program TRUNCATE (4). The initial structure factor phase angles up to 3 Å resolution were obtained by the molecular replacement (MR) method from the previously determined monomer structures in the dimeric forms in the fully oxidized and reduced states (PDB id 5B1A and 5B1B). Phase extension to 1.8 Å and 1.9 Å resolutions for the oxidized and reduced forms, respectively, were carried out by density modification using the CCP4 program DM (5) . The resultant phase angles ( MR/DM ) were used to calculate electron density maps (MR/DM electron density maps) with Fourier coefficients of F O exp(i MR/DM ). Structural refinement was carried out using the program REFMAC 5 (6) . The resultant phase angles were used to calculate an anomalous difference Fourier map. Statistics of the structural refinement are summarized in Table S1 . (6), and cytochrome c monomer (7) were used as molecular markers. A total of 2 mg of each marker was passed through the column. Elution volumes were determined, and a calibration curve was generated. The white circle represents CcO. 
